Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Dynavax Technologies Corporation has partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against COVID-19 infection; and a collaboration with Valneva SE to initiate a vaccine program for the coronavirus, COVID-19. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2019-02-28 | OSTRACH MICHAEL S | Senior Vice President | Sell | 35,444 | $8.94 | $316,764 | Yes |
| 2019-02-28 | OSTRACH MICHAEL S | Senior Vice President | Sell | 35,444 | $8.94 | $316,764 | Yes |
| 2018-06-08 | OSTRACH MICHAEL S | Senior Vice President | Sell | 4,000 | $15.53 | $62,100 | No |
Insider Smart
Insider Smart